684 related articles for article (PubMed ID: 30150001)
1. Metformin as an Anticancer Agent.
Vancura A; Bu P; Bhagwat M; Zeng J; Vancurova I
Trends Pharmacol Sci; 2018 Oct; 39(10):867-878. PubMed ID: 30150001
[TBL] [Abstract][Full Text] [Related]
2. Metformin and Breast Cancer: Molecular Targets.
Faria J; Negalha G; Azevedo A; Martel F
J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):111-123. PubMed ID: 30903363
[TBL] [Abstract][Full Text] [Related]
3. Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation.
Kim KH; Jeong YT; Kim SH; Jung HS; Park KS; Lee HY; Lee MS
Biochem Biophys Res Commun; 2013 Oct; 440(1):76-81. PubMed ID: 24041694
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial targets of metformin-Are they physiologically relevant?
Pecinová A; Brázdová A; Drahota Z; Houštěk J; Mráček T
Biofactors; 2019 Sep; 45(5):703-711. PubMed ID: 31343786
[TBL] [Abstract][Full Text] [Related]
5. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus.
Foretz M; Guigas B; Viollet B
Nat Rev Endocrinol; 2019 Oct; 15(10):569-589. PubMed ID: 31439934
[TBL] [Abstract][Full Text] [Related]
6. AMPK regulation of Raptor and TSC2 mediate metformin effects on transcriptional control of anabolism and inflammation.
Van Nostrand JL; Hellberg K; Luo EC; Van Nostrand EL; Dayn A; Yu J; Shokhirev MN; Dayn Y; Yeo GW; Shaw RJ
Genes Dev; 2020 Oct; 34(19-20):1330-1344. PubMed ID: 32912901
[TBL] [Abstract][Full Text] [Related]
7. Molecular targets of metformin antitumor action.
Sośnicki S; Kapral M; Węglarz L
Pharmacol Rep; 2016 Oct; 68(5):918-25. PubMed ID: 27362768
[TBL] [Abstract][Full Text] [Related]
8. Molecular action of metformin in hepatocytes: an updated insight.
Sliwinska A; Drzewoski J
Curr Diabetes Rev; 2015; 11(3):175-81. PubMed ID: 25808533
[TBL] [Abstract][Full Text] [Related]
9. Metformin in cancer.
Mallik R; Chowdhury TA
Diabetes Res Clin Pract; 2018 Sep; 143():409-419. PubMed ID: 29807101
[TBL] [Abstract][Full Text] [Related]
10. Anti-diabetic drug metformin: challenges and perspectives for cancer therapy.
Snima KS; Pillai P; Cherian AM; Nair SV; Lakshmanan VK
Curr Cancer Drug Targets; 2014; 14(8):727-36. PubMed ID: 25329671
[TBL] [Abstract][Full Text] [Related]
11. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
Guppy A; Jamal-Hanjani M; Pickering L
Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
[TBL] [Abstract][Full Text] [Related]
12. New Insight into the Effects of Metformin on Diabetic Retinopathy, Aging and Cancer: Nonapoptotic Cell Death, Immunosuppression, and Effects beyond the AMPK Pathway.
Hsu SK; Cheng KC; Mgbeahuruike MO; Lin YH; Wu CY; Wang HD; Yen CH; Chiu CC; Sheu SJ
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502359
[TBL] [Abstract][Full Text] [Related]
13. Metformin: from mechanisms of action to therapies.
Foretz M; Guigas B; Bertrand L; Pollak M; Viollet B
Cell Metab; 2014 Dec; 20(6):953-66. PubMed ID: 25456737
[TBL] [Abstract][Full Text] [Related]
14. Metformin, cancer and glucose metabolism.
Salani B; Del Rio A; Marini C; Sambuceti G; Cordera R; Maggi D
Endocr Relat Cancer; 2014; 21(6):R461-71. PubMed ID: 25273809
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibition of mTORC1 activation, DNA synthesis and proliferation in pancreatic cancer cells: dependence on glucose concentration and role of AMPK.
Sinnett-Smith J; Kisfalvi K; Kui R; Rozengurt E
Biochem Biophys Res Commun; 2013 Jan; 430(1):352-7. PubMed ID: 23159620
[TBL] [Abstract][Full Text] [Related]
16. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
[TBL] [Abstract][Full Text] [Related]
17. An update on mode of action of metformin in modulation of meta-inflammation and inflammaging.
Khodadadi M; Jafari-Gharabaghlou D; Zarghami N
Pharmacol Rep; 2022 Apr; 74(2):310-322. PubMed ID: 35067907
[TBL] [Abstract][Full Text] [Related]
18. Metabolic switching in the hypoglycemic and antitumor effects of metformin on high glucose induced HepG2 cells.
Lv Y; Tian N; Wang J; Yang M; Kong L
J Pharm Biomed Anal; 2018 Jul; 156():153-162. PubMed ID: 29705631
[TBL] [Abstract][Full Text] [Related]
19. Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis.
Griss T; Vincent EE; Egnatchik R; Chen J; Ma EH; Faubert B; Viollet B; DeBerardinis RJ; Jones RG
PLoS Biol; 2015 Dec; 13(12):e1002309. PubMed ID: 26625127
[TBL] [Abstract][Full Text] [Related]
20. Metformin suppresses glucose-6-phosphatase expression by a complex I inhibition and AMPK activation-independent mechanism.
Ota S; Horigome K; Ishii T; Nakai M; Hayashi K; Kawamura T; Kishino A; Taiji M; Kimura T
Biochem Biophys Res Commun; 2009 Oct; 388(2):311-6. PubMed ID: 19664596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
